Lyka Labs Ltd
₹59.70
(-1.13%)
Fri, 08 May 2026, 05:07 am
Lyka Labs Share Price Live Chart
1 Day
0 (0%)
No Result Found
Summary
Market Cap
221.28
Net Profit
7.93
P/B
3.48
Sector P/E
34.49
P/E
45.07
EV/EBITDA
19.69
Debt/Equity (Industry)
0.24
Interest Cover (Industry)
9.69
ROCE (Industry)
13.46
RONW (Industry)
12.65
ROE
5.25
ROCE
6.62
Debt/Equity
0.55
EPS (TTM)
0
Dividend Yield
0
Book Value
28.33
Interest Cover
5.90
Analysis
all
- Whilst loss making Lyka Labs has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by -11.3% per year.
- Whilst loss making Lyka Labs has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.
- Kunal's remuneration is about average for companies of similar size in India.
- NSEI:LYKALABS is up 20.2% outperforming the Pharmaceuticals industry which returned 6.8% over the past month.
- NSEI:LYKALABS is up 20.2% outperforming the market in India which returned 8% over the past month.
- Unable to evaluate Lyka Labs's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Lyka Labs's dividend against the top 25% market benchmark as the company has not reported any payouts.
- Lyka Labs's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- Debt is not well covered by operating cash flow (3.8%, less than 20% of total debt).
- Lyka Labs has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 58.16 | 58.16 | 58.16 | 58.16 | 58.16 |
| FII | 0.29 | 0.17 | 0.17 | 0.16 | 0.23 |
| DII | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 |
| Public | 40.88 | 41.00 | 41.00 | 41.02 | 40.94 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 88.21 | 72.02 | 65.86 | 55.83 | 49.67 | 39.64 | 23.45 |
| Fibonacci | 72.02 | 65.84 | 62.01 | 55.83 | 49.65 | 45.82 | 39.64 |
| Camarilla | 64.15 | 62.67 | 61.18 | 55.83 | 58.22 | 56.73 | 55.25 |
Pivots Level: Classic
R3
+32.38
88.21
R2
+16.19
72.02
R1
+10.03
65.86
S1
-6.16
49.67
S2
-16.19
39.64
S3
-32.38
23.45
Moving Average
Period
Value
10-EMA
60.48
20-EMA
59.18
30-EMA
58.87
50-EMA
60.11
100-EMA
66.36
200-EMA
78.76
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 29 Jan 2026 | board-meetings | Quarterly Results | |
| 12 Nov 2025 | board-meetings | Quarterly Results, Half Yearly Results, EGM, Change in Registered Address | |
| 08 Jul 2025 | agm | ||
| 31 Jan 2025 | egm | ||
| 15 Jul 2024 | agm | ||
| 01 Jul 2024 | agm | Annual General Meeting | 02 Aug 2024 |
| 18 Jan 2024 | egm | ||
| 10 Jul 2023 | agm | ||
| 21 Jun 2023 | agm | Annual General Meeting | 24 Jul 2023 |
| 21 Jan 2023 | egm |
Peer Comparison
Lyka Labs Ltd
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
Divis Laboratories Ltd
Cipla Ltd
Lupin Ltd
Lyka Labs Ltd About
Lyka Labs is engaged in the business of pharmaceutical and related activities, including research.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1976
Headquarters
CEO
Babulal Jain
Employees
Contact
Website
http://www.lykalabs.com
investorredressal@lykalabs.com; enquiry@lykalabs.c
Phone
91-02646-221422/220549
Location
4801/B & 4802/A, GIDC Industrial Estate, Ankleshwar, Gujarat, 393002
Lyka Labs Ltd Company History
| Year | History |
|---|---|
| 2012 |
|
| 2014 |
|
| 2016 |
|
| 2017 |
|
| 2021 |
|
Deals
| Client Name | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|
| GRAVITON RESEARCH CAPITAL LLP | Sell | 198593 | 164.19 | 05 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | Buy | 198593 | 164.08 | 05 Sept 2024 |
| GRAVITON RESEARCH CAPITAL LLP | Sell | 190740 | 147.92 | 22 Aug 2024 |
| GRAVITON RESEARCH CAPITAL LLP | Buy | 190740 | 147.84 | 22 Aug 2024 |
| MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | Buy | 230144 | 154.25 | 21 Aug 2024 |
| NK SECURITIES RESEARCH PRIVATE LIMITED | Sell | 183892 | 145.53 | 21 Aug 2024 |
| MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | Sell | 250000 | 154.28 | 21 Aug 2024 |
| NK SECURITIES RESEARCH PRIVATE LIMITED | Buy | 183892 | 145.37 | 21 Aug 2024 |
| QUANT MUTUAL FUND QUANT SMALL CAP FUND | Sell | 150000 | 101.93 | 02 Jun 2023 |
| PRABHULAL LALLUBHAI PAREKH | Buy | 185061 | 91.97 | 26 May 2023 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800